Lv42
420 积分 2026-08-12 加入
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
2个月前
已完结
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
2个月前
已完结
[Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)]
2个月前
已完结
Nanobody-A versatile tool for cancer diagnosis and therapeutics
2个月前
已完结
Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy
2个月前
已完结
Nanobody-based drug delivery systems for cancer therapy
2个月前
已完结
A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors
3个月前
已完结
Advance of nanobody drug conjugates (NDCs) for cancer therapy
3个月前
已完结
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates
3个月前
已完结